Listing a study does not mean it has been evaluated by the U. One of the mechanisms responsible for survival of these therapy-resistant hypoxic cells is (macro-)autophagy: a phenomenon in which cells provide themselves with energy (ATP) by digesting their own cell-organelles. Tumor hypoxia is a well-known factor negatively influencing outcome in many solid tumors, including small cell lung cancer. Bpi nite burn and hydroxychloroquine Plaquenil screening doctor Antimalarial drugs chloroquine Chloroquine pancreatic cancer Abstract. The PINC trial NCT01023477 examined the dosage efficacy of oral chloroquine CQ, an autophagy inhibitor, as a neoadjuvant therapy to reduce the volume, cause regression and decrease the recurrence of breast ductal carcinoma in situ DCIS, for any grade or ER/PR/Her2 status. Adjuvant Effect of Chloroquine on Gemcitabine The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U. S. Federal Government. Of the trials investigating chloroquine, 1 is phase 2 1 open and 1 is phase 3 1 open. Deficient DNA Mismatch Repair dMMR, H3F3A K28M, and IDH1 R132* are the most frequent biomarker inclusion criteria for chloroquine clinical trials. Thus, chloroquine might very well be able to increase overall survival in small cell lung cancer by sensitizing cells resistant to chemotherapy and radiotherapy. Chloroquine is a potent blocker of autophagy and has been demonstrated in a lab setting to dramatically enhance tumor response to radiotherapy, chemotherapy and even anti-hormonal therapy. Clinical trials cancer chloroquine Study protocol of a phase IB/II clinical trial of metformin., Adjuvant Effect of Chloroquine on Gemcitabine - Full Text. Macular thinning plaquenilLupus nephritis and plaquenilHydroxychloroquine bleeding and surgeryChloroquine storage tempCost of plaquenil in ireland The purpose of this study is to test the hypothesis that chloroquine will reduce the ability of ductal carcinoma in situ DCIS to survive and spread. Participants will receive either chloroquine standard dose 500mg/week or chloroquine low dose 250mg/week for 1 month prior to surgical removal of the tumor. Study of the Efficacy of Chloroquine in the Treatment of.. Chloroquine - My Cancer Genome. Chloroquine and hydroxychloroquine for cancer therapy. Clinical trials are research studies that involve people. The clinical trials on this list are for colon cancer treatment. All trials on the list are supported by NCI. NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. These findings support clinical study of chloroquine to lower rates of venous thromboembolism in patients with cancer. Trial registration. This study reports correlative data from two clinical trials that registered with clinicaltrials.gov, NCT01128296 May 21, 2010 and NCT01978184 November 7, 2013. Apr 11, 2012 Chloroquine as an Anti-autophagic Radiosensitizing Drug in Stage I-III Small Cell Lung Cancer Chloroquine The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.